Periodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes
T2DM_NLP
A Comparison of the Effects of Different Periodization-Based Strength Training Programs in Individuals With Type 2 Diabetes Mellitus
1 other identifier
interventional
48
1 country
1
Brief Summary
This randomized controlled study aims to compare the effects of different periodization-based strength training approaches in individuals with type 2 diabetes mellitus. Participants will be allocated to non-linear periodization, linear periodization, or control groups. The intervention program will be conducted for 8 weeks and will evaluate exercise capacity, muscle strength, quality of life, body composition, and metabolic parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes
Started May 2026
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 6, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 22, 2026
June 1, 2026
6 months
June 6, 2026
June 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise Capacity
Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT)
Baseline and after 8 week
Secondary Outcomes (8)
Change in Peripheral Muscle Strength
Baseline and after 8 weeks
Change in Hand Grip Strength
Baseline and after 8 weeks
Change in Diabetes Quality of Life Questionnaire Score
Baseline and after 8 weeks
Change in Body Fat Percentage
Baseline and after 8 weeks
Change in Skeletal Muscle Mass
Baseline and after 8 weeks
- +3 more secondary outcomes
Study Arms (3)
Non-linear Periodization Group
EXPERIMENTALParticipants will receive non-linear periodization-based strength training three times per week for 8 weeks.
Linear Periodization Group
EXPERIMENTALParticipants will receive linear periodization-based strength training three times per week for 8 weeks.
Control Group
ACTIVE COMPARATORParticipants will receive usual care and no structured exercise intervention during the study period.
Interventions
Participants will perform supervised non-linear periodization-based strength training three times per week for 8 weeks.
Participants will perform supervised linear periodization-based strength training three times per week for 8 weeks.
Participants will receive usual care and no structured exercise intervention during the study period.
Eligibility Criteria
You may qualify if:
- Adults aged between 18 to 65 years
- Diagnosis of Type 2 Diabetes Mellitus (T2DM)
- Not having participated in any structured exercise program within the last 6 months
- Willingness to participate in the study and provide written informed consent
You may not qualify if:
- Presence of nephropathy, retinopathy, or peripheral neuropathy
- Presence of neurological, cognitive, or orthopedic disorders that may affect outcome measurements
- Severe respiratory disease (Forced Expiratory Volume in the first second \[FEV1\] \<35% or Forced Vital Capacity \[FVC\] \<50%)
- Presence of ischemic heart disease or peripheral arterial disease
- History of any cardiovascular event within the last 6 months
- Current malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baskent University Hospital
Ankara, Ankara, 06790, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neslihan Duruturk, PhD
Baskent University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
June 6, 2026
First Posted
June 22, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share